Click a link below to view the mailing archive as if it had been sent to you.
| 2015-12-31 12:15 | | Gilead, Amgen, Shire: Key Bolt-On Biotech Deal Makers for 2016 and more... |
| 2015-12-31 00:15 | | Cancer Drugs: Strong Growth for Bristol’s Opdivo, Pfizer’s Ibrance and more... |
| 2015-12-30 12:15 | | Celgene Corporation to Continue Dominating Myeloma Market and more... |
| 2015-12-30 00:15 | | Will Valeant's CEO Recover? Will Valeant? and more... |
| 2015-12-29 12:15 | | Pennywise And Billion-Foolish: Troubling Data For Pfizer's Ian Read and more... |
| 2015-12-29 00:15 | | The Worst Johnson & Johnson Headlines in 2015 and more... |
| 2015-12-28 12:15 | | Why drug pricing will continue to loom large for pharma in 2016 and more... |
| 2015-12-27 12:15 | | The top biopharma trends for 2016 and more... |
| 2015-12-27 00:15 | | The biosimilars are coming. But how long will it be till they can make their mark? and more... |
| 2015-12-26 12:15 | | The Worst Regeneron Pharmaceuticals, Inc. Headlines in 2015 and more... |
| 2015-12-24 12:15 | | Amgen's PCSK9 outcomes trial to deliver data sooner than expected and more... |
| 2015-12-24 00:15 | | NewLink Genetics Vaccine May Improve How We Treat Pancreatic Cancer and more... |
| 2015-12-23 12:15 | | Which Biotechnologies Were Hyped (And Which Went Out Of Favor) In 2015 and more... |
| 2015-12-23 00:15 | | Did AbbVie Blow $21 Billion Buying Pharmacyclics? and more... |
| 2015-12-22 12:15 | | Actelion says selexipag to enter U.S. market in January and more... |
| 2015-12-22 00:15 | | FDA slaps Sun Pharma with warning letter on Indian plant and more... |
| 2015-12-21 12:15 | | Can Shire, Baxalta Merge Within Weeks On Improved Bid? and more... |
| 2015-12-21 00:15 | | Are Gilead Sciences, AstraZeneca Deals a Threat to AbbVie? and more... |
| 2015-12-19 12:15 | | After cancer drug trials crash, Threshhold sheds one-third of jobs and more... |
| 2015-12-19 00:15 | | Merck’s Share Price Has Been Volatile on Impending Drug Approvals and more... |
| 2015-12-18 12:15 | | Amgen PCSK-9 Prescription Volumes Ahead of Regeneron Pharmaceuticals and more... |
| 2015-12-18 00:15 | | Novartis poaches a Harvard oncologist to head up immuno-oncology program and more... |
| 2015-12-17 12:15 | | KaloBios Shares Plunge After Martin Shkreli Arrest and more... |
| 2015-12-17 00:15 | | Sanofi's poised for No. 1 in consumer health, but Bayer plans to fight back with M&A and more... |
| 2015-12-16 12:15 | | Merck's Vytorin Study Epitomizes Inherent Risks Of Major Clinical Trials and more... |
| 2015-12-16 00:15 | | FDA approves Merck drug to reverse effects of muscle relaxants and more... |
| 2015-12-15 12:15 | | FDA settles lawsuit, rescinds warning letter and more... |
| 2015-12-15 00:15 | | Amgen reacquires rights to three drugs from Glaxo in 48 countries and more... |
| 2015-12-14 12:15 | | It's official: FDA shoots past 2014's new drugs record with Roche lung cancer med nod and more... |
| 2015-12-13 12:15 | | Four More Reasons Why Investors Should Nix The Pfizer-Allergan Merger and more... |
| 2015-12-13 00:15 | | 3 Small-Cap Biotech Stocks With Big News Coming in 2016 and more... |
| 2015-12-12 00:15 | | Lilly and Merck pair 'breakthrough' therapies in latest cancer collaboration and more... |
| 2015-12-11 12:15 | | Galena Biopharma Gives Shareholders 3 More Reasons to Bury Their Heads in the Sand and more... |
| 2015-12-11 00:15 | | Amgen stalls Apotex's Neulasta biosim launch with court victory and more... |
| 2015-12-10 12:15 | | Raptor to advance neurodegenerative disorder drug in registration study and more... |
| 2015-12-10 00:15 | | How an obscure law brought us nasal flu spray — and new conflicts of interest and more... |
| 2015-12-09 12:15 | | With Paris spotlight on climate change, here's how Big Pharma stacks up and more... |
| 2015-12-09 00:15 | | Baxalta wins FDA approval with a treatment for a rare bleeding disease and more... |
| 2015-12-08 12:15 | | Will Glaxo's peers follow its anti-corruption lead in China? and more... |
| 2015-12-08 00:15 | | POZEN And Tribute Announce Plan To Proceed With Merger To Form Aralez Pharmaceuticals and more... |
| 2015-12-07 12:15 | | Brazilian anti-trust regulator raids medical device companies and more... |
| 2015-12-06 12:15 | | Novartis: Lymphoma study shows CART on track for 2017 U.S. submission and more... |
| 2015-12-06 00:15 | | Top 6 BioPharma Movers of the Week and more... |
| 2015-12-05 00:15 | | The 5 pharma vets and 3 newcomers that made BCG's '50 most innovative' firms list and more... |
| 2015-12-04 00:15 | | Martin Shkreli Admits He Messed Up: He Should've Raised Prices Even Higher and more... |
| 2015-12-03 12:15 | | Can AstraZeneca Live Up to Its $45 Billion Promise? and more... |
| 2015-12-03 00:15 | | More formulary exclusions are on their way as smaller PBMs get in on the action and more... |
| 2015-12-02 12:15 | | Pfizergan headed for top of ad-spend leaderboard--and not just in pharma and more... |
| 2015-12-02 00:15 | | Allergan investors still too 'skeptical' about a Pfizer merger, analyst says and more... |
| 2015-12-01 12:15 | | UnitedHealth Unit Favors Sanofi, Regeneron Cholesterol Drug and more... |
| 2015-12-01 00:15 | | PBMs Can Shut Down Valeant and more... |
